Medical devices, healthcare technology and the business of care
PMA SUPPLEMENT · P860057/S228

Carpentier-Edwards PERIMOUNT Theon RSR Pericardial Aortic Bioprosthesis with ThermaFix tissue process (2800TFX), Carpen

Edwards Lifesciences, LLC · Decision date Oct 28, 2026

MEDTECHLEDGER EXPLANATIONP860057/S228

What did the FDA decide?

This 30-day notice for supplement S228 to PMA P860057 states that the change is implementing an alternative supplier of a chemical manufacturing aid. The affected device is the Carpentier-Edwards PERIMOUNT Theon RSR Pericardial Aortic Bioprosthesis with ThermaFix tissue process (2800TFX), a replacement heart valve under product code DYE.

The notice does not describe the chemical manufacturing aid, the previous or alternative supplier, or any resulting process validation. It also does not state that safety or clinical effectiveness was independently demonstrated. The supplement type is a process change involving manufacturer, sterilizer, packager, or supplier, and it does not constitute a new approval of the valve system.

FDA approval order statement

implementing an alternative supplier of a chemical manufacturing aid
Regulatory pathway
PMA supplement
Supplement type
30-Day Notice
Clinical specialty
Cardiovascular
Decision date
Oct 28, 2026
FDA change category
Process Change - Manufacturer/Sterilizer/Packager/Supplier

FDA source record · MedtechLedger’s explanation describes the recorded change.

Regulatory record facts

Identifier
P860057/S228
Regulatory pathway
PMA supplement
Product code
DYE
Decision code
OK30
Decision date
Oct 28, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: replacement Heart-valve.

Product code
DYE
FDA device class
3

For the original device and its historical approval scope, see PMA P860057. Subsequent supplements may change the device or its indications.

FDA decision timeline

  1. P860057 · Original PMA

    EDWARDS LIFESCIENCES PERIMOUNT AORTIC AND MITRAL BIOPROSTHESES

  2. P860057/S228 received

    Application receipt date recorded by FDA.

  3. P860057/S228 · FDA decision

    30-Day Notice

Timeline entries are records held by MedtechLedger for P860057. View FDA’s full supplement list.

Related devices and submissions

Same PMA: P860057

Product / regulatory recordCompanyPathwayDecision dateSource
Edwards Lifesciences, LLCPMA approvalSep 26, 1991FDA

Explore the linked device profile

Regulatory context

A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Edwards Lifesciences, LLC

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
One Edwards Way, Irvine, CA, 92614

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records